
Akamai Technologies, Inc. (NASDAQ:AKAM – Free Report) – Analysts at Zacks Research reduced their Q2 2027 earnings per share (EPS) estimates for Akamai Technologies in a report released on Monday, October 26th. Zacks Research analyst Team now forecasts that the technology infrastructure company will earn $0.70 per share for the quarter, down from their prior forecast of $0.83. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Akamai Technologies’ current full-year earnings is $3.58 per share. Zacks Research also issued estimates for Akamai Technologies’ FY2027 earnings at $3.73 EPS.
Other analysts also recently issued research reports about the stock. Piper Sandler decreased their price objective on shares of Akamai Technologies from $158.00 to $120.00 and set an “overweight” rating on the stock in a report on Wednesday, October 21st. JPMorgan Chase & Co. increased their target price on shares of Akamai Technologies from $158.00 to $167.00 and gave the company a “neutral” rating in a report on Friday, September 25th. President Capital lifted their price target on shares of Akamai Technologies from $150.00 to $168.00 and gave the company a “buy” rating in a research report on Wednesday, September 30th. Wall Street Zen upgraded shares of Akamai Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, October 17th. Finally, TD Cowen boosted their price target on Akamai Technologies from $140.00 to $149.00 and gave the stock a “hold” rating in a research note on Friday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $146.00.
Read Our Latest Analysis on Akamai Technologies
Akamai Technologies Stock Performance
Shares of AKAM opened at $98.50 on Tuesday. The company has a 50-day simple moving average of $105.40 and a 200-day simple moving average of $112.22. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 1.23. The company has a market capitalization of $14.16 billion, a PE ratio of 35.43, a P/E/G ratio of 4.40 and a beta of 0.62. Akamai Technologies has a 52-week low of $70.82 and a 52-week high of $165.45.
Akamai Technologies (NASDAQ:AKAM – Get Free Report) last issued its earnings results on Thursday, August 6th. The technology infrastructure company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.57 by $0.02. Akamai Technologies had a net margin of 9.51% and a return on equity of 11.32%. The company had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same period in the previous year, the firm earned $1.73 EPS. The business’s revenue was up 5.4% on a year-over-year basis. Akamai Technologies has set its Q3 2026 guidance at 1.600-1.800 EPS and its FY 2026 guidance at 6.400-7.050 EPS.
Hedge Funds Weigh In On Akamai Technologies
Several hedge funds have recently added to or reduced their stakes in the business. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of Akamai Technologies in the second quarter valued at about $222,046,000. William Blair Investment Management LLC purchased a new position in shares of Akamai Technologies during the 2nd quarter worth approximately $181,508,000. Legal & General Group Plc purchased a new position in shares of Akamai Technologies during the 2nd quarter worth approximately $159,564,000. Atreides Management LP purchased a new position in shares of Akamai Technologies during the 2nd quarter worth approximately $107,640,000. Finally, Southpoint Capital Advisors LP acquired a new position in shares of Akamai Technologies during the 1st quarter worth approximately $91,880,000. 94.28% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, EVP Mani Sundaram sold 7,022 shares of the firm’s stock in a transaction on Friday, September 25th. The stock was sold at an average price of $125.62, for a total value of $882,103.64. Following the completion of the transaction, the executive vice president owned 14,625 shares in the company, valued at $1,837,192.50. This trade represents a 32.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Kim Salem-Jackson sold 2,013 shares of Akamai Technologies stock in a transaction on Friday, September 25th. The stock was sold at an average price of $128.00, for a total value of $257,664.00. Following the transaction, the executive vice president directly owned 57,197 shares of the company’s stock, valued at $7,321,216. This trade represents a 3.40% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,135 shares of company stock worth $1,467,221 over the last 90 days. 2.30% of the stock is currently owned by corporate insiders.
Akamai Technologies Company Profile
Akamai Technologies, Inc provides cloud, cybersecurity and content-delivery services that help organizations operate and protect applications, websites and digital media over the internet. Its distributed edge platform is designed to deliver online content closer to end users while improving performance, availability and resilience.
The company’s services include content delivery and application performance solutions, cloud computing capabilities, web and application security, distributed denial-of-service protection, bot management and zero-trust security tools.
Recommended Stories
- Five stocks we like better than Akamai Technologies
- Verizon’s Q3 Results Show Why SpaceX’s Spectrum Grab Isn’t a Major Threat
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
Receive News & Ratings for Akamai Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akamai Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
